Renvela
Active Ingredient(s): Sevelamer CarbonateFDA Approved: * October 19, 2007
Pharm Company: * GENZYME
Category: Hyperphosphatemia
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Contents 1 Chemistry and pharmacology 2 Medical uses 3 Contraindications 4 Adverse effects 5 Other eff... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.3 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
Renvela experiences
Any problems from taking renvela or it's generic sevelamer carbonate 800 mg? If so, please let me know. ## Hello, Ro...
1 REPLYRenvela
Do you take renvela before, during or after eating?...